首页> 外文期刊>American Journal of Transplantation >Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)
【24h】

Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)

机译:欧洲酒精性肝病的肝移植:来自ELTR(欧洲肝移植注册机构)的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Alcohol-related liver disease (ALD) is one of the most common indications for liver transplantation (LT). Long-term outcome after LT for ALD versus other etiologies is still under debate. The aim of this study was to compare outcome after LT of patients with ALD, viral (VIR), and cryptogenic cirrhosis. Donor, graft and recipient ELTR variables were analysed in transplants for alcoholic and nonalcoholic cirrhosis (1988–2005) and were correlated with patient survival. Causes of death and/or graft failure were compared between groups. Nine thousand eight hundred eighty ALD, 10 943 VIR, 1478 ALD + VIR and 2410 cryptogenic (CRYP) liver transplants were evaluated. One, 3, 5 and 10 years graft survival rates after LT in ALD patients were 84%, 78%, 73%, 58%, significantly higher than in VIR and CRYP (p = 0.04, p = 0.05). By multivariate analysis, ALD + VIR (RR 1.14) and viral alone (RR 1.06) were significant risk factors for mortality. De novo tumors, cardiovascular and social causes were causes of death/graft failure in higher percentage in ALD groups versus other etiologies. LT for ALD cirrhosis has a favorable outcome, however, hepatitis C virus co-infection seems to eliminate this advantage. Screening for de novo tumors and prevention of cardiovascular complications are essential to provide better long-term results.
机译:酒精相关性肝病(ALD)是肝移植(LT)的最常见适应症之一。长期使用ALD与其他病因后的长期结果仍存在争议。这项研究的目的是比较ALD,病毒性(VIR)和隐源性肝硬化患者LT的结局。在酒精和非酒精性肝硬化的移植物中分析了供体,移植物和受体的ELTR变量(1988-2005年),并与患者生存率相关。比较两组之间的死亡原因和/或移植失败。评估了988例ALD,10943例VIR,1478例ALD + VIR和2410例隐源性(CRYP)肝移植。 ALD患者LT后1、3、5和10年的移植物存活率分别为84%,78%,73%,58%,显着高于VIR和CRYP(p = 0.04,p = 0.05)。通过多变量分析,ALD + VIR(RR 1.14)和仅病毒(RR 1.06)是导致死亡的重要危险因素。与其他病因相比,ALD组的新生肿瘤,心血管和社会原因是死亡/移植失败的原因。 LT对于ALD肝硬化具有良好的疗效,但是,丙型肝炎病毒共感染似乎消除了这一优势。从头筛查肿瘤和预防心血管并发症对于提供更好的长期结果至关重要。

著录项

  • 来源
    《American Journal of Transplantation》 |2010年第1期|p.138-148|共11页
  • 作者单位

    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital of Padova, Padova, Italy;

    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital of Padova, Padova, Italy;

    ELTR, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Centre Hepato-Biliaire, Université Paris-Sud, Villejuif, France;

    ELTR, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Centre Hepato-Biliaire, Université Paris-Sud, Villejuif, France;

    ELTR, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Centre Hepato-Biliaire, Université Paris-Sud, Villejuif, France;

    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital of Padova, Padova, Italy;

    Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom;

    For a complete list of the centers, see http://www.eltr.org.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Alcohol; liver cirrhosis; liver transplantation; outcome;

    机译:酒精;肝硬化;肝移植;结果;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号